Event Details

Oral Presentations:

Development of subcutaneously administered RNAi therapeutic ARO-HBV for chronic hepatitis B virus infection

• Presentation Reference: PS-030
• Session: Parallel session: Parallel session: HBV Cure: Pre-clinical studies
• Date and Time: April 12, 2018 at 5:15 p.m. CET
• Authors: Christine Wooddell, et al.

ARO-AAT, a subcutaneous RNAi-based therapeutic for alpha-1 antitrypsin-related liver disease, demonstrates liver exposure-response and efficacy in preclinical studies

• Presentation Reference: PS-147
• Session: Parallel session: Clinical developments in metabolic and rare disease
• Date and Time: April 14, 2018 at 9:15 a.m. CET
• Authors: Christine Wooddell, et al.

Poster Presentation:

RNA interference therapy with ARC-520 Injection results in long term off-therapy antigen reductions in treatment naïve, HBeAg positive and negative patients with chronic HBV

• Presentation Reference: FRI-362
• Session: Viral hepatitis B/D: Therapy
• Session Date and Time: April 13, 2018 from 9 a.m. to 5 p.m. CET
• Authors: Man-Fung Yuen, et al.